One limited study on enteric lung AC and metastatic colorectal cancer presented a diagnostic gain of CDH17 and SATB2 [45], while another study on cytological samples from various sites did not find any benefit in adding the two markers [46]. This evidence concerns the gene SATB2 and metastatic colorectal cancer.